Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Antares Pharma (ATRS)
NASDAQ:ATRS
Antares Pharma (ATRS) Financial Statements
0 Followers
Antares Pharma Financial Overview
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 41.56M | $ 48.73M | $ 48.19M | $ 44.98M | $ 42.08M |
| Gross Profit | $ 22.79M | $ 29.76M | $ 31.76M | $ 28.54M | $ 25.64M |
| EBIT | $ -2.96M | $ 45.87M | $ 7.97M | $ 6.70M | $ 5.34M |
| EBITDA | $ -2.03M | $ 47.01M | $ 8.92M | $ 7.62M | $ 6.24M |
| Net Income Common Stockholders | $ -2.32M | $ 32.68M | $ 5.39M | $ 6.71M | $ 3.79M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 45.13M | $ 52.17M | $ 53.14M | $ 55.65M | $ 57.37M |
| Total Assets | $ 255.66M | $ 257.50M | $ 216.74M | $ 212.62M | $ 218.46M |
| Total Debt | $ 10.29M | $ 21.90M | $ 26.65M | $ 29.37M | $ 40.45M |
| Net Debt | $ -34.83M | $ -30.27M | $ -26.48M | $ -26.28M | $ -16.92M |
| Total Liabilities | $ 79.89M | $ 81.75M | $ 75.91M | $ 80.59M | $ 92.23M |
| Stockholders Equity | $ 65.24M | $ 119.11M | $ 126.22M | $ 132.03M | $ 140.83M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.96M | $ -5.98M | $ 16.21M | $ 5.16M | $ 794.00K |
| Operating Cash Flow | $ -4.88M | $ 9.49M | $ 18.72M | $ 6.43M | $ 1.98M |
| Investing Cash Flow | $ 666.00K | $ 1.11M | $ -2.50M | $ -1.27M | $ -1.18M |
| Financing Cash Flow | $ 17.00K | $ -2.05M | $ -3.98M | $ -15.69M | $ 1.72M |
Antares Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.